Sep 21, 2025 15:23
ASRT - Assertio Holdings, Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 0.71 0.01 (1.98%) | 0.0 (-0.35%) | 0.0 (-0.34%) | 0.0 (0.19%) | 0.0 (0.0%) | 0.0 (0.34%) | 0.0 (0.14%) | -0.01 (-1.61%) |
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- -0.17
- Diluted EPS:
- -0.17
- Basic P/E:
- -4.2497
- Diluted P/E:
- -4.2497
- RSI(14) 1m:
- 45.61
- VWAP:
- 0.72
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Sep 19, 2025 13:50
Feb 12, 2025 22:54
Jan 03, 2025 21:30
Dec 06, 2024 12:00
Jun 06, 2024 20:05
Jun 05, 2024 12:30
May 17, 2024 13:15
May 16, 2024 13:16
May 10, 2024 19:12